SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC)
CTIC 9.0900.0%Jun 26 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott who wrote (16)2/28/1998 10:10:00 AM
From: Bill Jackson  Read Replies (1) of 946
 
Scott; No solid news but there is a chance that there will be some positive news from the CT-2584 trials?(is that the number?)
I have spoken to several researchers and that approach seems to be worth investigatin as the MDM must be end run to be effective against cancers, and the fact that 2584 can be used again and again with no cellular immunity allows selective use of other methods in addition to it.

It could also be due to the Lysophyline trials that might get going into the next phase, but data will be a lot later for them, so I have hopes that the CT-2584 has scored some points and the data will come out over the next few weeks.

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext